A site that manufactured tanks for World War II is ready to tackle the next generation of global challenges as a bioscience research, development and commercial manufacturing facility.
The long-dormant, 25–acre Budd Companies site in northern Philadelphia was acquired by New York-based Plymouth Group in 2019 for $6.5 million, and the private equity firm has undertaken a major transformation of the property to accommodate pharmaceutical manufacturing.
Comments